Frontiers in Oncology

Original Research

Published on 05 Mar 2024

Stereotactic body radiotherapy as a viable treatment on extracranial oligometastases in melanoma patients: a retrospective multicentric study

in Skin Cancer

Victorine Trentesaux
Sophie Maiezza
Emilie Bogart
Marie-Cécile Le Deley
Emmanuel Meyer
Ludovic Vanquin
David Pasquier
Laurent Mortier
Xavier Mirabel

Frontiers in Oncology

doi 10.3389/fonc.2024.1322515

2,050 views
1 citation

Review

Published on 04 Mar 2024

Review of recent advances in managing periocular skin malignancies

in Skin Cancer

Daniel C. Trotier
Leslie Huang
Suzanne W. van Landingham
Adam R. Burr
Vincent T. Ma

Frontiers in Oncology

doi 10.3389/fonc.2024.1275930

4,280 views
2 citations

Review

Published on 26 Feb 2024

Multidisciplinary approach and treatment of acral and mucosal melanoma

in Skin Cancer

Ana Fortuna
Teresa Amaral

Frontiers in Oncology

doi 10.3389/fonc.2024.1340408

2,621 views
5 citations

Original Research

Published on 21 Feb 2024

Targeted therapy or immunotherapy in BRAF-mutated metastatic melanoma: a Spanish center’s decade of experience

in Skin Cancer

Chen Sun
Sofia España
Nina Richarz
Carme Solé-Blanch
Aram Boada
Anna Martinez-Cardús
Alan Chu
Zongwen Liu
Jose Luis Manzano

Frontiers in Oncology

doi 10.3389/fonc.2024.1322116

2,170 views
3 citations

Review

Published on 08 Feb 2024

Management of acral lentiginous melanoma: current updates and future directions

in Skin Cancer

Michelle M. Dugan
Matthew C. Perez
Lilit Karapetyan
Jonathan S. Zager

Frontiers in Oncology

doi 10.3389/fonc.2024.1323933

6,732 views
9 citations

Original Research

Published on 06 Feb 2024

Immunotherapy utilization in stage IIIA melanoma: less may be more

in Skin Cancer

Alexander E. Frey
Daniel M. Kerekes
Sajid A. Khan
Thuy T. Tran
Harriet M. Kluger
James E. Clune
Stephan Ariyan
Mario Sznol
Jeffrey J. Ishizuka
Kelly L. Olino

Frontiers in Oncology

doi 10.3389/fonc.2024.1336441

2,469 views
1 citation

Case Report

Published on 29 Jan 2024

Case report: Exceptional disease progression in a 70-year-old patient: generalized melanosis and melanuria in the course of metastatic melanoma - a case study

in Skin Cancer

Jacek Calik
Piotr Dzięgiel
Natalia Sauer

Frontiers in Oncology

doi 10.3389/fonc.2024.1332362

2,602 views
1 citation

Editorial

Published on 17 Jan 2024

Editorial: Non-cutaneous melanoma: new therapeutic insights

in Skin Cancer

Ernesto Rossi
Richard D. Carvajal

Frontiers in Oncology

doi 10.3389/fonc.2023.1362238

2,013 views
2 citations

Original Research

Published on 04 Jan 2024

Effectiveness and tolerability of chlormethine gel for the management of mycosis fungoides: a multicenter real-life evaluation

in Skin Cancer

Silvia Alberti-Violetti
Marco Ardigò
Cesare Massone
Alessandro Pileri
Raffaella Sala
Miriam Teoli
Vieri Grandi
Pietro Quaglino
Nicola Pimpinelli
Emilio Berti

Frontiers in Oncology

doi 10.3389/fonc.2023.1298296

3,343 views
4 citations

Case Report

Published on 19 Dec 2023

Case report: Parsonage-turner syndrome in a melanoma patient treated by BRAF/MEK inhibitors after immune checkpoint inhibitors

in Skin Cancer

Charlotte Bonnefin
Fanny Duval
Marie Rouanet
Marie Kostine
Emilie Gerard

Frontiers in Oncology

doi 10.3389/fonc.2023.1268693

1,618 views
1 citation

Brief Research Report

Published on 19 Dec 2023

Detectable ctDNA at the time of treatment cessation of ipilimumab and nivolumab for toxicity predicts disease progression in advanced melanoma patients

in Skin Cancer

Lydia Warburton
Anna Reid
Benhur Amanuel
Leslie Calapre
Michael Millward
Elin Gray

Frontiers in Oncology

doi 10.3389/fonc.2023.1280730

1,932 views
6 citations

Brief Research Report

Published on 04 Dec 2023

Extended long-term follow-up of metastatic melanoma patients treated with immunotherapy: late relapses and second primary melanomas

in Skin Cancer

David R. Minor
Kevin B. Kim
R. Krishna M. Karuturi
Mohammed Kashani-Sabet

Frontiers in Oncology

doi 10.3389/fonc.2023.1241917

8,200 views

Original Research

Published on 30 Nov 2023

Outcome and treatment-related adverse events of combined immune checkpoint inhibition with flipped dosing in a real-world cohort of 79 patients with metastasized melanoma

in Skin Cancer

Charlotte Nübel
Teresa Amaral
Ulrike Leiter
Lukas Flatz
Andrea Forschner

Frontiers in Oncology

doi 10.3389/fonc.2023.1256800

1,863 views

Case Report

Published on 24 Nov 2023

Case Report: Balancing immune responses – multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanoma

in Skin Cancer

Katrin Pape
Maria Protopapa
Muriel Schraad
Falk Steffen
Frauke Zipp
Stefan Bittner

Frontiers in Oncology

doi 10.3389/fonc.2023.1303141

2,106 views
3 citations

Original Research

Published on 08 Nov 2023

Cost items in melanoma patients by clinical characteristics and time from diagnosis

in Skin Cancer

Alessandra Buja
Claudia Cozzolino
Anna Zanovello
Ruggero Geppini
Andrea Miatton
Manuel Zorzi
Mariagiovanna Manfredi
Emanuela Bovo
Paolo Del Fiore
Saveria Tropea

Frontiers in Oncology

doi 10.3389/fonc.2023.1234931

1,608 views
1 citation

Original Research

Published on 30 Oct 2023

A transcriptional evaluation of the melanoma and squamous cell carcinoma TIL compartment reveals an unexpected spectrum of exhausted and functional T cells

in Skin Cancer

Cheryl M. Cameron
Brian Richardson
Jackelyn B. Golden
Yee Peng Phoon
Banumathi Tamilselvan
Lukas Pfannenstiel
Samjhana Thapaliya
Gustavo Roversi
Xing-Huang Gao
Leah L. Zagore

Frontiers in Oncology

doi 10.3389/fonc.2023.1200387

2,958 views